A new study published in JAMA Network Open contends that women may lose more weight on semaglutides like Ozempic than men.

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Ozempic continues to surge in popularity for managing type 2 diabetes and off-label weight loss, but are there natural ...

Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.

The term "Ozempic face" is not a medical term, but some use it to describe this type of appearance after weight loss. Here what's fact and fiction.

A new study linked weight loss drugs known as semaglutides (Ozempic is one) to a lower risk of opioid overdoses. Doctors tell ...

WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...

New research suggests GLP-1 medications can blunt people's cravings for potentially addictive substances like opioids.

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Hidradenitis suppurativa is a chronic inflammatory skin condition that impacts up to two percent of people in the U.S.

The head of Ozempic manufacturer Novo Nordisk on Tuesday defended the high price of the company’s highly sought-after obesity ...

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes ...